Insight

Radioligand Therapy Offers Hope to Lung Cancer Patients – Oncogene Cancer Research

Photo taken from nature.com

Sep 22, 2024, 18:11

Radioligand Therapy Offers Hope to Lung Cancer Patients – Oncogene Cancer Research

Oncogene Cancer Research posted the following on LinkedIn:

“Radioligand Therapy is offering hope to cancer patients through targeted nuclear medicine.

Here our Co-founder and two fellow patient advocates participate in a virtual demo showcasing how this therapy kills tumour cells. Quite a therapeutic and cathartic demo for lung cancer patients!

We hope this and other great innovations will bring real benefits to our lung cancer patient community. It’s why we’re focused on more research.”

Radioligand Therapy

Source: Oncogene Cancer Research/LinkedIn

#cancer patients cancer care cancer treatment Lung cancer OncoDaily Oncogene Cancer Research Oncology Patient Advocacy radioligand therapy Research targeted nuclear medicine therapeutic innovation

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology